Skip to main content

Table 3 Analysis of control and diabetic groups (with or without CVD), results presented as mean ± standard deviation (SD) of MCFI and percentage activated platelets

From: Flow cytometric analysis of platelets type 2 diabetes mellitus reveals ‘angry’ platelets

MoAb

Controls (n = 30)

Diabetes without CVDs (n = 30)

Diabetes with CVD (n = 30)

CD41-PE

21.08 ± 8.74

40.18 ± 14.56*

47.81 ± 24.49*

CD42b-PE

14.43 ± 1.84

24.78 ± 11.98*

24.09 ± 7.27*

CD62P-PE X-mean

30.86 ± 11.37

17.96 ± 1.95*

17.79 ± 2.266*

CD62P-PE % activated platelets

71.01 ± 16.20

92.65 ± 3.67*

92.11 ± 4.31*

CD63-PE X-mean

16.40 ± 3.32

13.05 ± 3.68**

13.38 ± 3.12**

CD63-PE % activated platelets

37.84 ± 17.59

54.39 ± 32.92**

61.24 ± 29.73**

  1. n = 10,000 platelets total analysed for each participant of each group
  2. Statistically significant differences: * p < 0.001, ** p < 0.005
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840